Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Tubulins - The Target for Anticancer Therapy

Author(s): N.G. Vindya, Nishant Sharma, Mukesh Yadav and K.R. Ethiraj

Volume 15, Issue 1, 2015

Page: [73 - 82] Pages: 10

DOI: 10.2174/1568026615666150112115805

Price: $65

Abstract

Tubulin has picked up great focus as a major target in drug discovery and consequently, tubulin inhibitors have pulling in a considerable attention as anticancer agents. Numerable naturally occurring agents have focused on tubulin system act as an imperative target of cancer chemotherapy. Substantial number of tubulin inhibitors has been discovered so far and these agents are classified as indicated by their interaction. They are colchicine site binder, vinca- alkaloid related drugs and those interacting with the Taxol binding site and functioning as stabilising agents. We review the recent advances in the advancement of tubulin interfering agents and will render the current trend in the improvement of tubulin inhibitors as anticancer agents.

Keywords: Tubulins, Anticancer agents, Laulimalide, Macrolides, Chalcones, Spongistatin.

« Previous
Graphical Abstract


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy